<?xml version="1.0" encoding="UTF-8" standalone="yes" ?>
<!-- SwishCommand noindex -->
<rss version="2.0">
<channel>
  <title>ComplianceHome: FDA Events</title>
  <link>http://www.compliancehome.com/</link>
  <description>ComplianceHome is one of the Web's largest library of resources for compliance management of HIPAA, SOX, FISMA, GLBA, FDA, COOP &amp; COG, FFIEC, Basel II, OSHA and ISO 27002/17799. Visit our directories which are the best source on White papers, related news articles, resources on the web, training, webinars, conferences, rules &amp; regulation overview, ask the expert, job and search on vendors, solutions &amp; products.</description>
<image>
  <url>http://www.compliancehome.com/images/rsslogo.gif</url>
  <title>ComplianceHome</title>
  <link>http://www.compliancehome.com/</link>
</image>
  <language>en-us</language>
  <item>
    <title>CDRH's NumberOne Priority  Are You Prepared?</title>
    <pubDate>Mon, 21 Jul 2008 00:00:00 CST</pubDate>
    <link>http://www.compliancehome.com/events/FDA/Webinars/details11148.html</link>
    <description>2008-07-31  None &lt;br&gt;  Sign up your entire team to listen in and discover:&lt;br /&gt;&lt;br /&gt;    * The nuts and bolts of the FDAs postmarket surveillance authority under the FDAAA&lt;br /&gt;    * How postmarket surveillance compares with postapproval studies&lt;br /&gt;    * When and how postmarket surveillance can be imposed&lt;br /&gt;    * Three pitfalls to avoid when preparing for postmarket surveillance&lt;br /&gt;    * Strategies for meeting regulatory expectations for complying with postmarket surveillance requirements&lt;br /&gt;    * 10 critical details to include in a postmarket surveillance plan&lt;br /&gt;    * The role of postmarket surveillance in the bigger picture of the FDAs Postmarket Transformation Initiative&lt;br /&gt;    * Potential consequences of noncompliance&lt;br /&gt;    * Four ways postmarket surveillance impacts other key FDA compliance requirements&lt;br /&gt;</description>
    <guid isPermaLink="false">http://www.compliancehome.com/events/FDA/Webinars/details11148.html</guid>
  </item>
  <item>
    <title>Compliance Boot Camp 2008 : Validation, Quality and Compliance Training</title>
    <pubDate>Fri, 11 Jul 2008 00:00:00 CST</pubDate>
    <link>http://www.compliancehome.com/events/FDA/Conferences/details11126.html</link>
    <description>2008-09-22 - 2008-09-26  None &lt;br&gt; You'll learn:&lt;br /&gt;&lt;br /&gt;    * Which validation deliverables the FDA expects and what they should contain&lt;br /&gt;    * How to identify, document and report computerized system validation deviations&lt;br /&gt;    * How the FDA defines a systems risk and mitigation strategy that you can deploy&lt;br /&gt;    * Proactive steps you can take to avoid CSV and Part 11 Form 483s and warning letters&lt;br /&gt;    * The five supporting pillars required for effective CSV, including: system management and monitoring, system change management, risk management, vendor management and CSV methodology management&lt;br /&gt;    * Update on the new draft Part 11 regulation&lt;br /&gt;</description>
    <guid isPermaLink="false">http://www.compliancehome.com/events/FDA/Conferences/details11126.html</guid>
  </item>
  <item>
    <title>Navigating the FDA's New Requirements for eCTD Submissions</title>
    <pubDate>Mon, 07 Jul 2008 00:00:00 CST</pubDate>
    <link>http://www.compliancehome.com/events/FDA/Conferences/details11112.html</link>
    <description>2008-07-28 - 2008-07-29  Philadelphia, PA &lt;br&gt; n Navigating the FDA's New Requirements for eCTD Submissions, you will:&lt;br /&gt;&lt;br /&gt;    * Discover the top 10 reasons sponsors receive a refuse-to-file from the FDA on their eCTD submissions&lt;br /&gt;    * Gain clarity on the acronyms and jargon of eCTD and electronic submissions&lt;br /&gt;    * Effectively budget and develop project plans for eCTD submissions&lt;br /&gt;    * Understand why and how to start producing eCTD submissions at the IND phase&lt;br /&gt;    * Master the documentation requirements for electronic datasets for stability, nonclinical and clinical, and better communicate these requirements to colleagues early in the drug development cycle&lt;br /&gt;    * Assure the output of your in-house system is valid for FDA review&lt;br /&gt;    * Learn about the eCTD pilot  what it does, why you need it, how it works and how to make it work for you&lt;br /&gt;    * Learn about the FDA's Electronic Submissions Gateway and how to prepare to submit your eCTDs electroni</description>
    <guid isPermaLink="false">http://www.compliancehome.com/events/FDA/Conferences/details11112.html</guid>
  </item>
</channel>
</rss>
